Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2015-12-28 | cell-based therapeutic product consisting of retinal pigment epithelial (RPE) cells | BioTime (USA - CA) Cell Cure Neurosciences (Israel) | age-related macular degeneration (AMD) |
Granting of a Fast Track status |
2015-12-29 | allogeneic ex-vivo expanded placental adherent stromal cells | Pluristem Therapeutics (Israel) | severe preeclampsia |
Granting of the orphan status in the US |
2015-11-19 | (R)-6-(2-fluorophenyl)-N-(3-(2-((2-methoxyethyl)amino)ethyl)phenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine dihydrochloride | Arqule (USA - MA) | cholangiocarcinoma |
Granting of the orphan status in the US |
2015-05-21 | echinomycin | OncoImmune (USA) | acute myeloid leukemia |
Granting of the orphan status in the US |
2015-11-24 | acetyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-cysteinyl-D-glutaminyl-D-cystenyl-D-arginyl-D-arginyl-D-lysyl-D-asparaginylmaide disulfide | Genus Oncology (USA - MA) | acute myeloid leukemia |
Granting of the orphan status in the US |
2016-04-28 | human Wilms tumor protein 1 peptides (Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu, Ser-Gly-Gln-Ala-Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu-ProSer-Cys-Leu-Glu-Ser, Arg-Ser-Asp-Glu-Leu-Val-Arg-His-His-Asn-Met-His-Gln-Arg-Asn-Met-Thr-LysLeu and Pro-Gly-Cys-Asn-Lys-Arg-Tyr-Phe-Lys-Leu-Ser-His-Leu-Gln-Met-His-Ser-Arg-Lys-His-ThrGly) | Sellas Life Sciences Group (Switzerland) | acute myeloid leukemia |
Granting of the orphan status in the EU |
2016-04-25 | trifluridine and tipiracil hydrochloride | Taiho Pharmaceutical (Japan)/Servier (France) | patients with an advanced form of colorectal cancer who are no longer responding to other therapies adult patients with metastatic colorectal cancer |
Granting of a Market Authorisation in the EU |
2017-06-27 | sarilumab | Sanofi (France) Regeneron Pharmaceutical (USA - NY) | rheumatoid arthritis | Granting of a Market Authorisation in the EU |
2016-09-15 | lenvatinib | Eisai (Japan) | advanced or metastatic renal cell carcinoma | Granting of a Market Authorisation in the EU |
2016-01-13 | Medtronic (Ireland) | spine metastases |
Product launch | |
2015-09-18 | fusidic acid | Cempra (USA - NC) | acute bacterial skin and skin structure infections (ABSSSI) |
Granting of a Fast Track status |
2016-04-11 | sodium benzoate | Syri Limited (UK) | hyperargininaemia |
Granting of the orphan status in the EU |
2016-04-11 | sodium benzoate | Syri Limited (UK) | arginosuccinic aciduria |
Granting of the orphan status in the EU |
2015-12-08 | two allogenic irradiated pancreatic tumour cell lines | Aduro Biotech (USA - CA)/Medpace Germany (Germany) | pancreatic cancer |
Positive opinion for the granting of the orphan status in the EU |
2016-01-11 | entolimod | TMC Pharma Services (UK) | acute radiation syndrome |
Granting of the orphan status in the EU |
2016-01-11 | live attenuated Listeria monocytogenes transfected with plasmids encoding the HPV-16E7 protein fused to a truncated fragment of the Lm protein listeriolysin O | Dr Ulrich Granzer (Germany) | anal cancer | Granting of the orphan status in the EU |
2016-01-15 | secukinumab | Novartis (Switzerland) | ankylosing spondylitis |
Granting of a Market Authorisation in the US |
2015-12-14 | ImmunID (France) | Granting of a patent | ||
2015-08-18 | LSD1 (Lysine Specific Demethylase-1) inhibitor | Oryzon Genomics (Spain) | Granting of a patent | |
2015-12-08 | hepatitis B vaccine | Abivax (France) Center for genetic Engineering and Biotechnology (CIGB) (Cuba) | chronic hepatitis B |
Granting of a patent |
© 2024 Biopharmanalyses - Powered by Samacom+